Thermo Fisher Scientific TMO Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.28B-21.4% | $9.88B+145% | $2.01B-56.9% | $4.6B-35.1% | $4.17B-24.4% | ||
| $22.32B-4.5% | $28.71B+29.7% | $22.3B-6.3% | $24.58B-3.5% | $23.38B-1.1% | ||
| $10.66B+14.2% | $10.57B+13.5% | $10.18B+8.1% | $9.64B+3.8% | $9.33B+0.1% | ||
| $55.19B+18.7% | $49.36B+7.7% | $49.29B+5.5% | $47.25B+7.8% | $46.49B+6.0% | ||
| $113.28B+14.4% | $110.34B+13.4% | $103.02B+2.6% | $101.23B+2.8% | $99.04B+2.0% | ||
| $2.93B+2.2% | $2.71B-5.0% | $2.85B+7.1% | $2.81B+8.3% | $2.87B+8.9% | ||
| $14.62B+11.0% | $15.19B+13.9% | $14.89B+2.0% | $12.72B-13.9% | $13.17B-5.5% | ||
| $42.95B+26.4% | $39.17B+26.1% | $35.48B+1.1% | $35.03B-0.5% | $33.99B-4.0% | ||
| —— | —— | —— | —— | —— | ||
| $60.63B+11.4% | $59.16B+11.4% | $57.35B+11.5% | $55.9B+11.9% | $54.45B+12.2% | ||
| $51.93B+5.2% | $53.41B+7.7% | $51.02B+4.1% | $50.51B+6.5% | $49.39B+8.5% | ||
| $113.28B+14.4% | $110.34B+13.4% | $103.02B+2.6% | $101.23B+2.8% | $99.04B+2.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Thermo Fisher Scientific's total assets?
- Thermo Fisher Scientific (TMO) holds $113.28B in total assets, up 14.4% year over year.
- How much debt does Thermo Fisher Scientific have?
- Thermo Fisher Scientific carries $43.2B in total debt against $51.9B of shareholders' equity, a debt-to-equity ratio of 0.83.
- How much cash does Thermo Fisher Scientific have?
- Thermo Fisher Scientific holds $3.3B in cash and equivalents.
- Can Thermo Fisher Scientific cover its short-term obligations?
- Its current ratio is 1.53 — current assets exceed current liabilities.
- Where does Thermo Fisher Scientific's balance sheet data come from?
- Every line is extracted from Thermo Fisher Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
